Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Halo Collective Inc. N.HALO

Alternate Symbol(s):  N.HALO.WT.C | HCANF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis


NEO:HALO - Post by User

Halo Collective Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by talladega73on Feb 06, 2013 2:33pm
147 Views
Post# 20947795

RE: RE: RE: RE: RE: RE: RE: About the major shareh

RE: RE: RE: RE: RE: RE: RE: About the major shareh

Scorpion in broad general terms I agree with you. It really doesn't matter who paid what for their stock but I know that Sprott bought a large chunk of the bought deal underwriting that Apogee did in May 6 2011 and I suspect Coeur was in on that deal also. You may wish to checkout the Apogee website for the details on this underwriting as it was 89 million shares. 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities